Clear Search sequence regions


Islet transplantation is the most exciting treatment option for individuals afflicted with Type 1 diabetes. However, the severe shortage of human pancreas and the need to use risky immunosuppressive drugs to prevent transplant rejection remain two major obstacles for the routine use of islet transplantation in diabetic patients. Successful development of a bioartificial pancreas using the approach of microencapsulation with perm-selective coating of islets with biopolymers for graft immunoisolation holds tremendous promise for diabetic patients because it has great potential to overcome these two barriers. In this chapter, we provide a detailed description of the microencapsulation process.

Citation

Emmanuel C Opara, John P McQuilling, Alan C Farney. Microencapsulation of pancreatic islets for use in a bioartificial pancreas. Methods in molecular biology (Clifton, N.J.). 2013;1001:261-6

Expand section icon Mesh Tags

Expand section icon Substances


PMID: 23494435

View Full Text